ACTRN12615000506594已完成4 期
A prospective, double-blind, randomised, placebo-controlled study to evaluate the safety and efficacy of a complementary medicine formulation, to help reduce duration and severity of cold and flu symptoms, in otherwise health adults.
Prof Luis Vitetta0 个研究点目标入组 200 人开始时间: 2015年5月20日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •Healthy volunteers with no cold or flu symptoms
- •Capable of providing informed consent
- •Able to attend the designated clinics
排除标准
- •If they are using any other form of vitamin or herbal product for symptom relief during the episode;
- •If they are pregnant, breastfeeding (females) or attempting to conceive;
- •If they have active opportunistic infections or opportunistic malignancies requiring acute treatment;
- •If they are using any pharmaceutical product(s) for symptom relief during the episode;
- •If they are on immuno-suppressive medication such as corticosteroids or any other immune-modulating therapies;
- •If they have had a cold and flu vaccination in the last 6 months;
- •If they have uncontrolled diabetes, uncontrolled hypertension, liver or renal disease;
- •If the have a BMI >35;
- •If they have any other acute, recurrent or chronic ear, nose, throat and respiratory tract disease other than the common cold (eg bronchitis, tonsillitis, allergic rhinitis, otitis, bronchitis, asthma etc);
- •If they have experienced unintended weight loss of more than 15% of body weight in last six months;
- •If they are active substance abusers (alcohol or drug dependency); or
- •If they have known or suspected hypersensitivity to ingredients of the trial intervention.
研究者
相似试验
进行中（未招募）
1 期
A prospective, double-blind, randomised, placebo-controlled trial on the efficacy and safety of Neiromidin 20 mg tablets in the treatment of patients with lumbosacral radiculopathyumbosacral radiculopathyEUCTR2019-002632-90-PLOlainfarm AS458
进行中（未招募）
1 期
A prospective, double-blind, randomised, placebo-controlled trial on the efficacy and safety of Neiromidin 20 mg tablets in the treatment of patients with lumbosacral radiculopathyEUCTR2019-002632-90-LVOlainfarm AS458
进行中（未招募）
1 期
A prospective, double-blind, randomised, placebo-controlled trial on the efficacy and safety of Neiromidin 20 mg tablets in the treatment of patients with lumbosacral radiculopathyumbosacral radiculopathyEUCTR2019-002632-90-CZOlainfarm AS458
已完成
3 期
A double-blind, randomised, placebo-controlled study to evaluate the effect of an orally-dosed herbal extract, Testofen, for the treatment of Benign Prostatic Hyperplasia (BPH) symptoms in otherwise healthy males.ACTRN12615001242516Amanda Rao100
进行中（未招募）
1 期
A prospective, double-blind, randomised, placebo-controlled trial on the efficacy and safety of Neiromidin 20 mg tablets in the treatment of patients with lumbosacral radiculopathyEUCTR2019-002632-90-BGOlainfarm AS458